TCON: Utang marang Ekuitas traconpharma.com

Simbol resmi perusahaan TRACON Pharmaceuticals, Inc (TCON)

TRACON Pharmaceuticals (TCON) develops monoclonal antibodies using a virtual manufacturing model, outsourcing drug synthesis to third-party US facilities to minimize risk. Current price action for the total debt-to-equity ratio stands at 0.00. The business relies on the development of targeted anti-tumor agents, focusing on blocking the blood supply to cancerous tissues to improve therapy quality.

TCON: Total Utang marang Modal TRACON Pharmaceuticals Inc. 04.07.2022 - 04.08.2024
Barang utama TRACON Pharmaceuticals, Inc

To find fundamental support in TRACON Pharmaceuticals (TCON), it is essential to evaluate the debt-to-equity ratio, which measures the degree of financial leverage and dependence on creditors. By analyzing the current total debt leverage, an investor will see a critical stage of business wind-down and the depletion of remaining liquidity for liquidation, rendering the asset extremely unreliable.

Analisis perusahaan pesaing

TEM (tempus.com) - Total Utang marang Modal|Rasio Utang marang Ekuitas QGEN (Qiagen NV)|Utang marang Ekuitas Ionis Pharma (IONS)|Repligen Inc. - Rasio Utang marang Ekuitas|Total Utang marang Modal RNA (Avidity Biosciences)|Total Utang marang Modal crisprtx.com CRSP|WGS: Rasio Total Utang marang Ekuitas|Ultragenyx Pharmaceutical Inc. - Utang Agregat marang Modal|Beam Therapeutics Corp (BEAM) - Utang marang Ekuitas|Sarepta Corp - Rasio Kabeh Utang marang Dana Pribadi|TWST (Twist Bioscience) - Total Utang marang Modal|Total Utang marang Modal 10xgenomics.com|Total Utang marang Modal NTLA|Rasio Total Utang marang Ekuitas Stoke Therapeutics Inc STOK|Utang marang Ekuitas BioLife Corp BLFS|Wave Pharma (WVE) - Utang marang Modal|MAZE - Utang marang Ekuitas|SION (sionnatx.com) - Rasio Utang marang Ekuitas|PRME (Prime Medicine) - Rasio Total Utang marang Ekuitas|Taysha Gene Therapies Inc - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas uniQure Corp|MeiraGTx Corp - Utang Agregat marang Ekuitas|Total Utang marang Modal RGNX|SLDB (solidbio.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal OCGN (Ocugen)|Total Utang marang Modal Pacific Biosciences of California, Inc. PACB|BNTC - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi DSGN (Design Corp)|Rocket Pharmaceuticals (RCKT) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas 4dmoleculartherapeutics.com|LXEO (Lexeo Therapeutics Inc.) - Total Utang marang Modal|Total Utang marang Modal Korro Bio, Inc|Total Utang marang Modal EDIT|Rasio Total Utang marang Ekuitas Silence Therapeutics Corp SLN|Total Utang marang Modal PRQR (ProQR Therapeutics)|Codexis Inc (CDXS) - Utang marang Modal|SGMO: Rasio Total Utang marang Ekuitas|NAUT - Total Utang marang Modal|MGX (Metagenomi, Inc) - Rasio Total Utang marang Ekuitas|DTIL: Utang Agregat marang Modal|GBIO (Generation Bio Co) - Total Utang marang Modal|boundlessbio.com (BOLD) - Koefisien Total Utang marang Modal|Total Utang marang Modal XCUR|Rasio Total Utang marang Ekuitas imunon.com IMNN|Total Utang marang Modal PHIO (Phio Pharmaceuticals Corp.)|Total Utang marang Modal Mustang Bio Inc MBIO|RNAZ - Utang marang Ekuitas|BNGO: Utang marang Ekuitas|Applied DNA Sciences, Inc. (APDN) - Utang marang Ekuitas|BLUE - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas IPA|OMGA (Omega Therapeutics Corp) - Utang Agregat marang Modal|Total Utang marang Modal OMIC|Rasio Total Utang marang Ekuitas regulusrx.com RGLS|Utang marang Ekuitas Syros Pharmaceuticals, Inc. SYRS|Telesis Bio Inc. (TBIO) - Utang marang Modal|UBX - Utang marang Ekuitas